Literature DB >> 25756935

Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Peter Rye1, Alex Chin2, Janice Pasieka3, Benny So4, Adrian Harvey3, Gregory Kline5.   

Abstract

The authors sought to define the 95th percentile of plasma renin activity (PRA) in a sample of patients with confirmed primary aldosteronism (PA) prior to adjustment of medications as a practical "first-look" test to identify those with very low ultimate likelihood of having PA. The aldosterone to renin ratio (ARR) was measured without adjustment of antihypertensive medications, with further workup as appropriate. Two groups were defined: patients with surgically "confirmed PA" (n=58) and patients with "high-probability PA" (n=59), defined as having any of the following: computed tomography-confirmed adrenal adenoma plus lateralizing adrenal vein sampling (AVS) without surgery, high ARR and hypokalemia but nonlateralizing AVS, or ARR more than four times the upper limit of normal. The PRA 95th percentile was 1.0 ng/mL/h. All outliers had hypokalemia and two had adrenal adenomas. There was no difference between the confirmed and high probability groups. In the absence of highly suspicious clinical features, patients with unadjusted PRA >1.0 ng/mL/h do not warrant further investigation for PA.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25756935      PMCID: PMC8032086          DOI: 10.1111/jch.12523

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  35 in total

1.  Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.

Authors:  V M Montori; G L Schwartz; A B Chapman; E Boerwinkle; S T Turner
Journal:  Mayo Clin Proc       Date:  2001-09       Impact factor: 7.616

2.  Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.

Authors:  Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle; Robert M Kisabeth; Stephen T Turner
Journal:  Clin Chem       Date:  2002-11       Impact factor: 8.327

3.  Renal damage in primary aldosteronism: results of the PAPY Study.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Massimo Mannelli; Mee-Jung Matterello; Domenico Montemurro; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Achille Cesare Pessina; Franco Mantero
Journal:  Hypertension       Date:  2006-06-26       Impact factor: 10.190

Review 4.  New genetic insights in familial hyperaldosteronism.

Authors:  Richard V Jackson; Anthony Lafferty; David J Torpy; Constantine Stratakis
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

5.  Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.

Authors:  Gary L Schwartz; Stephen T Turner
Journal:  Clin Chem       Date:  2005-02       Impact factor: 8.327

6.  Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism.

Authors:  Evelyn Fischer; Felix Beuschlein; Martin Bidlingmaier; Martin Reincke
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

7.  Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients.

Authors:  J Sirén; M Välimäki; K Huikuri; A Sivula; P Voutilainen; R Haapiainen
Journal:  World J Surg       Date:  1998-04       Impact factor: 3.352

8.  A clinical prediction score to diagnose unilateral primary aldosteronism.

Authors:  Elselien M Küpers; Laurence Amar; Alain Raynaud; Pierre-François Plouin; Olivier Steichen
Journal:  J Clin Endocrinol Metab       Date:  2012-08-23       Impact factor: 5.958

9.  Familial and phenotypic associations of the aldosterone Renin ratio.

Authors:  Samantha Alvarez-Madrazo; Sandosh Padmanabhan; Bongani M Mayosi; Hugh Watkins; Peter Avery; A Michael Wallace; Robert Fraser; Eleanor Davies; Bernard Keavney; John M Connell
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

10.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

View more
  9 in total

Review 1.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 2.  Approach to the Patient with an Incidental Adrenal Mass.

Authors:  Xin He; Patricia R Peter; Richard J Auchus
Journal:  Med Clin North Am       Date:  2021-09-09       Impact factor: 5.456

Review 3.  Primary Aldosteronism: Practical Approach to Diagnosis and Management.

Authors:  James Brian Byrd; Adina F Turcu; Richard J Auchus
Journal:  Circulation       Date:  2018-08-21       Impact factor: 29.690

Review 4.  Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12       Impact factor: 4.741

5.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

6.  Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-18       Impact factor: 3.738

7.  Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Authors:  Peter Rye; Alex Chin; Janice Pasieka; Benny So; Adrian Harvey; Gregory Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

8.  Screening for Primary Aldosteronism: Whom and How?

Authors:  Michael Doumas; Vasilios Athyros; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

9.  Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism.

Authors:  Rene Baudrand; Francisco J Guarda; Jasmine Torrey; Gordon Williams; Anand Vaidya
Journal:  J Clin Endocrinol Metab       Date:  2016-07-18       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.